Establishing Patient-Derived Xenograft Models for Lung Cancer Therapeutics
Patient-derived xenograft (PDX) models have become an invaluable tool in lung cancer research, providing a more clinically relevant platform for studying tumor biology and therapeutic responses. Unlike traditional cell line xenografts, PDX models involve implanting fresh tumor tissues directly obtained from lung cancer patients into immunodeficient mice. This approach preserves the histological architecture, genetic heterogeneity,…
